This is a recently updated guidance that discusses How to apply for a clinical trial including eligibility, phases, model IMPDs, costs, and how to make changes to your application.
This guidance covers the below topics
The guidance was last updated on Last updated 24 June 2021
111 views 0 comments Post not marked as likedThe views expressed in this publication do not necessarily reflect the views of any guidance of government, health authority, it's purely my understanding. This Blog/Web Site is made available by a regulatory professional, is for educational purposes only as well as to give you general information and a general understanding of the pharmaceutical regulations, and not to provide specific regulatory advice. By using this blog site you understand that there is no client relationship between you and the Blog/Web Site publisher. The Blog/Web Site should not be used as a substitute for competent pharma regulatory advice and you should discuss from an authenticated regulatory professional in your state. We have made every reasonable effort to present accurate information on our website; however, we are not responsible for any of the results you experience while visiting our website and request to use official websites.